Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs10163167 | chr15:83229395 | A/G | 2.23E-5 | 476 | 31.18 | 30.3 | 28.02 | KM Plot |
PRAD | rs10164756 | chr2:47167265 | G/T | 3.11E-6 | 491 | 30.8 | 32.4 | 36.77 | KM Plot |
PRAD | rs10164794 | chr2:178797973 | T/C | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10164920 | chr2:178784543 | G/A | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10165085 | chr2:47167695 | C/G | 3.11E-6 | 491 | 30.8 | 32.4 | 36.77 | KM Plot |
PRAD | rs10165192 | chr2:178798326 | T/C | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10165196 | chr2:178798345 | T/A | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10165299 | chr2:178798400 | T/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs10168605 | chr2:178779985 | C/A | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10170290 | chr2:178782133 | T/C | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10170607 | chr2:178782433 | T/C | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10170914 | chr2:178785905 | C/T | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10171079 | chr2:178785897 | G/A | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10171486 | chr2:178786320 | G/A | 4.16E-5 | 493 | 30.8 | 31.93 | 20.48 | KM Plot |
PRAD | rs10176133 | chr2:178798169 | A/T | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |